Medical Training AIMedical Weight Loss Management
You'll be able to evaluate candidates for pharmacologic obesity treatment, compare GLP-1 receptor agonist options, and manage titration and side effects with confidence.
What this track covers
This track covers the pathophysiology of obesity and the clinical use of GLP-1 receptor agonists in weight management, including patient selection, titration strategies, and monitoring for adverse effects. It's built for clinicians who prescribe or co-manage obesity pharmacotherapy and want a structured way to sharpen decision-making on real-world cases.
What you will practice
- Screening patients for GLP-1 therapy candidacy and contraindications
- Comparing mechanism of action across available GLP-1 and dual-agonist agents
- Sequencing titration schedules and adjusting for tolerability
- Recognizing and managing common and serious side effects
- Counseling patients on expectations, lifestyle integration, and follow-up
Simulator scenario
A patient with obesity and type 2 diabetes presents for a follow-up visit reporting nausea and slowed weight loss progress after a recent dose increase, requiring the clinician to reassess the titration plan and address side effects.
Board question topics
- GLP-1 receptor agonist mechanisms of action
- Contraindications and precautions for obesity pharmacotherapy
- Titration and dose adjustment principles
- Monitoring and managing adverse effects
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free